Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Kerui Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the development and production of steroid hormones and Vitamin D derivatives. The company is a significant manufacturer of Active Pharmaceutical Ingredients (APIs) and finished drug products, particularly synthetic Vitamin D analogs used in treating metabolic bone diseases and dermatological conditions. Their product portfolio includes key treatments such as Calcitriol, Alfacalcidol, and Calcipotriol. Fujian Kerui maintains high-standard manufacturing facilities that adhere to global Good Manufacturing Practice (GMP) requirements, enabling them to supply both the Chinese domestic market and international clients. The company is recognized for its strong R&D capabilities in the synthesis of complex steroid molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fujian Kerui.